Ebr Systems logo

Ebr Systems(ASX) EBR

Market CapA$105.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-75%
5 YearN/A
1 Year-89%
1 Month-45%
A$0.16
+10.71%
+0.01Today
Ebr Systems last closing stock price
MetricPriceDate
Last closeAUD 0.142026-10-12
Ebr Systems stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-44%AUD 0.252026-10-05
1 month-45.1%AUD 0.262026-09-11
3 month-62.67%AUD 0.382026-07-14
Year to date-84.36%AUD 0.902025-12-31
1 year-89.35%AUD 1.322025-10-10
3 year-80.42%AUD 0.722023-10-13
Since inception-75.44%AUD 0.962021-11-24

Ebr Systems Financials at a Glance

Market Cap

A$105.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$6.38M

Net Income (TTM)

-$60.42M

EPS (TTM)

-A$0.10

P/E Ratio

-1.41

Dividend

A$0.00

Beta (Volatility)

0.17 (Low)

Price

A$0.16

Volume

7,115,658

Open

A$0.14

Previous Close

A$0.16

Daily Range

A$0.14 - A$0.17

52-Week Range

A$0.13 - A$1.47

Estimated Earnings Date

Nov 12, 2026

EBR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ebr Systems

EBR Systems, Inc. is a pioneering company in the medical devices sector, specializing in implantable devices that utilize wireless technology for tissue stimulation. The flagship product, the WiSE cardiac resynchronization therapy system, offers a unique solution to traditional pacing challenges by delivering pacing signals directly to the heart's left ventricle.

Products and Services
  • WiSE cardiac resynchronization therapy system for heart pacing
  • Innovative wireless technology for improved patient outcomes
  • Focus on overcoming traditional pacing lead challenges
Growth Outlook
  • Significant market potential in the cardiac device sector
  • Increasing demand for non-invasive medical technologies
  • Expansion plans to enhance product offerings and market reach
Financial Highlights
  • Recent quarterly revenue of 2.57 million USD, showing growth
  • Trailing twelve months (TTM) revenue of 9.5 million USD, indicating upward trend
  • Current ratio of 2.12, reflecting strong liquidity position
EBR Systems, Inc. has established itself as a leader in innovative cardiac solutions, addressing critical needs in the medical device industry. The company's focus on wireless technology positions it well for future growth, particularly as the demand for advanced cardiac therapies continues to rise. Recent financial performance indicates a positive trajectory, with increasing revenues and a solid liquidity position, making it an intriguing option for potential investors interested in the healthcare sector.
AI Generated • Sep 22, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

135

CEO

John Graham McCutcheon, MBA

Website

www.ebrsystemsinc.com

Headquarters

Sunnyvale, CA 94085, US

EBR Financials

Key Financial Metrics (TTM)

Gross Margin

14.52%

Operating Margin

-900.44%

Net Income Margin

-947.48%

Return on Equity

-169.40%

Return on Capital

-56.62%

Return on Assets

-43.59%

Earnings Yield

-70.92%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$105.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

753.31M

Volume

7.12M

Avg. Volume

2.91M

Financials (TTM)

Gross Profit

$925.70K

Operating Income

-$57.42M

EBITDA

-$55.70M

Operating Cash Flow

-$65.35M

Capital Expenditure

-$8.81M

Free Cash Flow

-$74.16M

Cash & ST Invst.

$85.90M

Total Debt

$59.65M

Ebr Systems Performance Analysis

Ebr Systems annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 2,507,702N/A
Ebr Systems sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30201.8%
Q42025-12-3185.6%
Q12026-03-31146.2%
Q22026-06-3010.0%
Ebr Systems annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.02-86.0%
20232023-12-31USD -0.023.4%
20242024-12-31USD -0.023.8%
20252025-12-31USD -0.02-4.7%
Ebr Systems sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-309.3%
Q42025-12-31-15.7%
Q12026-03-3188.0%
Q22026-06-30-810.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$2.57M

+1416.8%

Gross Profit

$334.80K

+296.6%

Gross Margin

13.01%

N/A

Market Cap

A$105.46MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$781.21K

N/A

Employees

135

N/A

Net Income

-$17.04M

-42.4%

EBITDA

-$15.73M

-51.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$85.90M

+5.1%

Total Debt

$59.65M

+6.2%

Accounts Receivable

$2.89M

+37.8%

Inventory

$17.58M

+242.4%

Long Term Debt

$17.43M

-68.5%

Short Term Debt

$42.22M

+1874.2%

Return on Assets

-43.59%

N/A

Return on Invested Capital

-66.30%

N/A

Free Cash Flow

-$19.42M

-57.0%

Operating Cash Flow

-$16.66M

-45.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SLD.AXSaluda Medical, Inc.
A$0.40-4.82%
CYC.AXCyclopharm Limited
A$0.46-3.19%
SOM.AXSomnoMed Limited
A$0.26-3.70%
IPD.AXImpediMed Limited
A$0.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$6.67-0.89%
INTCIntel
$101.35-3.20%
NOKNokia
$9.90-4.44%
NVDANvidia
$226.32-1.29%

Questions About EBR

What is the current price of Ebr Systems?

Ebr Systems is trading at A$0.16 per share.

What is the 52-week range for Ebr Systems?

Over the past 52 weeks, Ebr Systems has traded between A$0.13 and A$1.47.

How much debt does Ebr Systems have?

As of the most recent reporting period, Ebr Systems reported total debt of $86.14M.

How much cash does Ebr Systems have on hand?

Ebr Systems reported $85.67M in cash and cash equivalents in its most recent financial results.

What is Ebr Systems’s dividend yield?

Ebr Systems does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services